Comparing to the TGF-β1 groups, Neferine treatment alone and combined with OXA groups resulted in a down-regulated mRNA and protein expression of Vimentin and N-cadherin, concomitant with an up-regulated expression of E-cadherin in TGF-β1-treated HCC cells. The gene discussed is VIM; the disease is hepatocellular carcinoma.